SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies Ltd (540737)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price

₹703 18.00 (2.63%)

As on 24-Jun'26 16:59

Shree Ganesh Remedies Ltd (540737)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540737 NSE: Pharmaceuticals & Drugs | Small Cap | Shree Ganesh Remed. Share Price

₹703 18.00 (2.63%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹902 Cr.
Current Price
₹703
52-Week Low / High
₹381 / 705
TTM EPS
₹13.8
TTM Sales
₹109 Cr.
Book Value per Share
₹127
P/E Ratio
50.78
Higher than its 5-year historical median
Industry PE
48.5
Price to Book (P/B)
5.54
Lower than its 5-year historical median
Price to Sales (P/S)
8.26
Higher than its 5-year historical median
EV/EBITDA
24.17
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
17.28%
Outperforms industry median
Return on Capital Employed (ROCE)
19.53%
Outperforms industry median
Return on Assets (ROA)
12.21%
Operating Profit Margin
36.1%
Net Profit Margin
21.27%
Gross Profit Margin
36.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-13.74%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-6.22%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-17.85%
Asset Quality
Promoter Holding
72.84%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹150 Cr.
Equity
₹12.8 Cr.
Face Value
₹10
All Time Low / High
₹22.07 / 950.05

Shree Ganesh Remedies stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Somewhat Good

Valuation

Somewhat Overvalued

Price Trend

Weak
Q.1 Is Shree Ganesh Remedies Ltd a good quality company?
Shree Ganesh Remedies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Shree Ganesh Remedies Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Shree Ganesh Remedies Ltd vs industry peers?
Shree Ganesh Remedies Ltd revenue CAGR is 13.20%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Shree Ganesh Remedies Ltd?
Promoters hold 72.84% of the Shree Ganesh Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Shree Ganesh Remedies Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 18.09% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shree Ganesh Remedies Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 12.4%26.2%27.7%27%32.6%27.5%32.5%22.5%27.8%19.5%-
Value Creation
Index
-0.10.91.00.91.31.01.30.61.00.4-

Growth Parameters

Sales 15.519.927.335.358.449.171.391.4126109109
Sales YoY Gr.-28%37.3%29.5%65.5%-16%45.3%28.2%37.8%-13.7%-
Adj EPS 1.12.834.76.77.59.612.419.51713.8
YoY Gr.-167.9%5.6%57.7%41.9%11.9%27.3%29.9%56.6%-12.4%-
BVPS (₹) 15.718.623.72834.841.450.969.795.1113.1127
Adj Net
Profit
12.53.65.78.19.111.61626.621.918
Cash Flow from Ops. 00-0.9-5.23.93.313.417.130.530.7-
Debt/CF from Ops. 00-2.6-0.10.60.101.91.21.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 24.1%13.2%15.1%-13.7%
Adj EPS 36.2%20.5%21.3%-12.4%
BVPS24.5%26.6%30.5%19%
Share Price - 17.2% 21% 15.7%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
716.616.118.321.419.720.721.525.416.411.5
Op. Profit
Mgn %
12.520.51924.818.727.825.226.933.236.132.1
Net Profit
Mgn %
6.112.713.316.213.918.516.217.521.120.216.3
Debt to
Equity
000.100.1000.40.30.30.1
Working Cap
Days
234223207200153224194197164209121
Cash Conv.
Cycle
16413497968812593908311391

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1620273558497191126109
Operating Expenses + 14162227473553688469
Manufacturing Costs111122581115
Material Costs9101518362237475736
Employee Cost 11222236810
Other Costs 3345898778
Operating Profit 2459111418234239
Operating Profit Margin (%) 12.4%20.5%19.0%24.8%18.7%27.8%25.1%25.7%33.2%36.1%
Other Income + 0021424134
Exceptional Items 0000000000
Interest 0000000012
Depreciation 11112334610
Profit Before Tax 2469131318203831
Tax 11223355108
Profit After Tax 1356101013152823
PAT Margin (%) 7.0%13.3%17.2%17.7%16.5%19.9%18.8%16.6%22.3%21.3%
Adjusted EPS (₹)1.23.03.95.28.08.111.112.121.918.0
Dividend Payout Ratio (%)0%0%19.10%18%14%18%4.50%4.10%0%0%

Valuation of Shree Ganesh Remed. - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1416293442506287122145
Share Capital 119991012131313
Reserves 1315202533405075109132
Debt +0021200323029
Long Term Debt0000000302929
Short Term Debt0020200210
Minority Interest0000000000
Trade Payables12244691586
Others Liabilities 123344681819
Total Liabilities 16213641526177143178200

Fixed Assets

Net Fixed Assets +44614161927588195
Gross Block99122125304277105128
Accumulated Depreciation556791115192533
CWIP 000002315179
Investments 00447300518
Inventories334761314182522
Trade Receivables67610171318282022
Cash Equivalents 1391234121610
Others Assets 24765711121424
Total Assets 16213641526177143178200

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 00-1-54313173031
PBT 0069131318203831
Adjustment 000-0-6-8-26611
Changes in Working Capital 00-7-14-3-22-4-5-2
Tax Paid 000000-4-6-8-10
Cash Flow From Investing Activity + 00-3-0-3-1-12-51-33-36
Capex 001-0-0-0-15-49-31-23
Net Investments 00-40-3-13-2-2-13
Others 00000000-00
Cash Flow From Financing Activity + 008-0-0-1-13910-1
Net Proceeds from Shares 00800001170
Net Proceeds from Borrowing 000000-0000
Interest Paid 0000000-0-1-2
Dividend Paid 000000-2-1-10
Others 00-0-0-0-112841
Net Cash Flow 004-512057-6

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)8.0617.3120.7519.9525.3521.1824.0220.4126.8717.28
ROCE (%)12.4226.1527.6827.0432.6327.5132.4722.4627.8319.53
Asset Turnover Ratio11.080.960.921.250.871.040.840.810.59
PAT to CFO Conversion(x)00-0.2-0.830.40.311.131.071.35
Working Capital Days
Receivable Days116.30119.6087.5079.8082.30111.4081.2091.9068.4069.80
Inventory Days75.4054.2047.7055.7037.5067.7067.5062.9060.9077
Payable Days39.3058.40525639.8083.4077.3096.5075.1072

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Shree Ganesh Remedies Ltd FAQs

The current trading price of Shree Ganesh Remed. on 24-Jun-2026 16:59 is ₹703.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Shree Ganesh Remed. stood at ₹902.5 Cr

The latest P/E ratio of Shree Ganesh Remed. as of 23-Jun-2026 is 50.78.

The latest P/B ratio of Shree Ganesh Remed. as of 23-Jun-2026 is 5.54.

The 52-week high of Shree Ganesh Remed. is ₹705.0 and the 52-week low is ₹381.1.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shree Ganesh Remed. is ₹109 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Shree Ganesh Remedies Ltd is a average quality company.

The key valuation ratios of Shree Ganesh Remedies Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shree Ganesh Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Shree Ganesh Remedies Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: